Structure Therapeutics, Inc. (GPCR)
22.28
-1.63
(-6.82%)
USD |
NASDAQ |
Oct 13, 16:00
22.30
+0.02
(+0.09%)
After-Hours: 20:00
Structure Therapeutics EPS Diluted (TTM) : -3.080 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.080 |
| March 31, 2026 | -2.692 |
| December 31, 2025 | -2.458 |
| September 30, 2025 | -3.653 |
| June 30, 2025 | -3.126 |
| March 31, 2025 | -2.577 |
| December 31, 2024 | -2.318 |
| September 30, 2024 | -2.215 |
| June 30, 2024 | -2.239 |
| Date | Value |
|---|---|
| March 31, 2024 | -2.315 |
| December 31, 2023 | -2.508 |
| September 30, 2023 | -2.30 |
| June 30, 2023 | -2.098 |
| March 31, 2023 | -1.854 |
| December 31, 2022 | -1.525 |
| June 30, 2022 | -1.201 |
| March 31, 2022 | -0.7805 |
| December 31, 2021 | -0.4225 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Eli Lilly & Co. | 29.43 |
| Novo Nordisk A/S | 4.092 |
| Pfizer Inc. | 0.7552 |
| Viking Therapeutics, Inc. | -4.662 |
| Liquidia Corp. | 1.364 |